Geron reported $550.8M in Market Capitalization this October of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Amgen USD 195.44B 5.55B Jun/2026
Cassava Sciences USD 82M 14M Mar/2026
Cytokinetics USD 11.55B 3.36B Jun/2026
Exelixis USD 18.9B 4.43B Oct/2026
Genmab DKK 17.1B 88.06B Jun/2026
Gilead Sciences USD 206.51B 21.7B Oct/2026
Incyte USD 26.22B 1.63B Oct/2026
MacroGenics USD 184M 82M Mar/2026
Novartis USD 266.01B 25.42B Oct/2026
Novavax USD 1.09B 316M Dec/2025